Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Piperacillin sodium & tazobactam sodium
All injection strengths: not a benefit
Piperacillin & Tazobactam For Injection · DIN 02402068 · 2 g & 250 mg · injection Pd-2.25g vial
Off-Formulary Interchangeable, not an ODB benefitMarketed · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot an ODB benefit; this DIN is on the ministry's EAP drug list (August 2026): submit an Exceptional Access request through SADIE with the clinical rationale; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Piperacillin & Tazobactam For Injection · DIN 02402068
Manufacturer: Auro Pharma Inc.; listing date 2021-08-31
Health Canada: Marketed since 2021-06-09 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients PIPERACILLIN (PIPERACILLIN SODIUM) 2 G/VIAL, TAZOBACTAM (TAZOBACTAM SODIUM) 0.25 G/VIAL · company Auro pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordPiperacillin & Tazobactam For Injection: Formulary list price $10.13 per unit (the source does not state the unit; exact figure $10.1300). What the ministry pays, not the patient.
Ministry pays: $10.1300 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02402068)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02402068).
DIN 02402068: Piperacillin & Tazobactam For Injection
Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y
Item: 081216101; group id 30; item number 0062; lccId None; manufacturer id AUR
Source form: Inj Pd-2.25g Vial Pk; strength: 2g & 250mg
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed)
Source prices (unrounded): $10.1300; ministry $10.1300
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02402068
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88693
Interchangeable products
Piperacillin & Tazobactam for Injection · DIN 02308444 · $10.1300
Piperacillin & Tazobactam for Injection · DIN 02362619 · $10.1300
Piperacillin and Tazobactam for Inj · DIN 02401312 · $10.1300
Tazocin · DIN 02170817 · not recorded
Shortage status: resolved shortage (ended February 18, 2025); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02402068
Shortage record checked October 6, 2026
Piperacillin & Tazobactam for Injection · DIN 02362619 · 2 g & 250 mg · injection Pd-2.25g vial
Off-Formulary Interchangeable, not an ODB benefitMarketed · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot an ODB benefit; this DIN is on the ministry's EAP drug list (August 2026): submit an Exceptional Access request through SADIE with the clinical rationale; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Piperacillin & Tazobactam for Injection · DIN 02362619
Manufacturer: Sterimax Inc.; listing date 2016-06-29
Health Canada: Marketed since 2011-08-29 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients PIPERACILLIN (PIPERACILLIN SODIUM) 2.00 G/VIAL, TAZOBACTAM (TAZOBACTAM SODIUM) 0.25 G/VIAL · company Sterimax inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordPiperacillin & Tazobactam for Injection: Formulary list price $10.13 per unit (the source does not state the unit; exact figure $10.1300). What the ministry pays, not the patient.
Ministry pays: $10.1300 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02362619)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02362619).
DIN 02362619: Piperacillin & Tazobactam for Injection
Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y
Item: 081216101; group id 30; item number 0062; lccId None; manufacturer id STE
Source form: Inj Pd-2.25g Vial Pk; strength: 2g & 250mg
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed)
Source prices (unrounded): $10.1300; ministry $10.1300
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02362619
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84762
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402068 · $10.1300
Piperacillin & Tazobactam for Injection · DIN 02308444 · $10.1300
Piperacillin and Tazobactam for Inj · DIN 02401312 · $10.1300
Tazocin · DIN 02170817 · not recorded
Shortage status: resolved shortage (ended November 15, 2024); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02362619
Shortage record checked October 6, 2026
Piperacillin & Tazobactam For Injection · DIN 02402076 · 3 g & 375 mg · injection Pd-3.375g vial
Off-Formulary Interchangeable, not an ODB benefitMarketed · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot an ODB benefit; this DIN is on the ministry's EAP drug list (August 2026): submit an Exceptional Access request through SADIE with the clinical rationale; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Piperacillin & Tazobactam For Injection · DIN 02402076
Manufacturer: Auro Pharma Inc.; listing date 2021-08-31
Health Canada: Marketed since 2021-06-09 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G/VIAL, PIPERACILLIN (PIPERACILLIN SODIUM) 3 G/VIAL · company Auro pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordPiperacillin & Tazobactam For Injection: Formulary list price $15.20 per unit (the source does not state the unit; exact figure $15.2000). What the ministry pays, not the patient.
Ministry pays: $15.2000 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02402076)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02402076).
DIN 02402076: Piperacillin & Tazobactam For Injection
Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y
Item: 081216097; group id 30; item number 0063; lccId None; manufacturer id AUR
Source form: Inj Pd-3.375g Vial Pk; strength: 3g & 375mg
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed)
Source prices (unrounded): $15.2000; ministry $15.2000
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02402076
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88694
Interchangeable products
Piperacillin & Tazobactam for Injection · DIN 02308452 · $15.2000
Piperacillin & Tazobactam for Injection · DIN 02362627 · $15.2000
Piperacillin & Tazobactam for Injection · DIN 02391538 · $15.2000
Piperacillin and Tazobactam for Inj · DIN 02401320 · $15.2000
Piperacillin/Tazobactam powder for Inj. · DIN 02370166 · $15.2000
Tazocin · DIN 02170795 · not recorded
Shortage status: resolved shortage (ended February 18, 2025); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02402076
Shortage record checked October 6, 2026
Piperacillin & Tazobactam for Injection · DIN 02362627 · 3 g & 375 mg · injection Pd-3.375g vial
Off-Formulary Interchangeable, not an ODB benefitMarketed · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot an ODB benefit; this DIN is on the ministry's EAP drug list (August 2026): submit an Exceptional Access request through SADIE with the clinical rationale; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Piperacillin & Tazobactam for Injection · DIN 02362627
Manufacturer: Sterimax Inc.; listing date 2016-06-29
Health Canada: Marketed since 2011-08-29 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients PIPERACILLIN (PIPERACILLIN SODIUM) 3.000 G/VIAL, TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G/VIAL · company Sterimax inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordPiperacillin & Tazobactam for Injection: Formulary list price $15.20 per unit (the source does not state the unit; exact figure $15.2000). What the ministry pays, not the patient.
Ministry pays: $15.2000 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02362627)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02362627).
DIN 02362627: Piperacillin & Tazobactam for Injection
Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y
Item: 081216097; group id 30; item number 0063; lccId None; manufacturer id STE
Source form: Inj Pd-3.375g Vial Pk; strength: 3g & 375mg
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed)
Source prices (unrounded): $15.2000; ministry $15.2000
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02362627
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84763
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402076 · $15.2000
Piperacillin & Tazobactam for Injection · DIN 02308452 · $15.2000
Piperacillin & Tazobactam for Injection · DIN 02391538 · $15.2000
Piperacillin and Tazobactam for Inj · DIN 02401320 · $15.2000
Piperacillin/Tazobactam powder for Inj. · DIN 02370166 · $15.2000
Tazocin · DIN 02170795 · not recorded
Shortage status: resolved shortage (ended September 13, 2024); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02362627
Shortage record checked October 6, 2026
Piperacillin & Tazobactam For Injection · DIN 02402084 · 4 g & 500 mg · injection Pd-4.5g vial
Off-Formulary Interchangeable, not an ODB benefitMarketed · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot an ODB benefit; this DIN is on the ministry's EAP drug list (August 2026): submit an Exceptional Access request through SADIE with the clinical rationale; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Piperacillin & Tazobactam For Injection · DIN 02402084
Manufacturer: Auro Pharma Inc.; listing date 2021-08-31
Health Canada: Marketed since 2021-06-09 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients PIPERACILLIN (PIPERACILLIN SODIUM) 4 G/VIAL, TAZOBACTAM (TAZOBACTAM SODIUM) 0.5 G/VIAL · company Auro pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordPiperacillin & Tazobactam For Injection: Formulary list price $20.27 per unit (the source does not state the unit; exact figure $20.2700). What the ministry pays, not the patient.
Ministry pays: $20.2700 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02402084)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02402084).
DIN 02402084: Piperacillin & Tazobactam For Injection
Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y
Item: 081216102; group id 30; item number 0064; lccId None; manufacturer id AUR
Source form: Inj Pd-4.5g Vial Pk; strength: 4g & 500mg
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed)
Source prices (unrounded): $20.2700; ministry $20.2700
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02402084
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88695
Interchangeable products
Piperacillin & Tazobactam for Injection · DIN 02308460 · $20.2700
Piperacillin & Tazobactam for Injection · DIN 02362635 · $20.2700
Piperacillin and Tazobactam for Inj · DIN 02401339 · $20.2700
Piperacillin/Tazobactam powder for Inj. · DIN 02370174 · $20.2700
Tazocin · DIN 02170809 · not recorded
Shortage status: resolved shortage (ended February 18, 2025); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02402084
Shortage record checked October 6, 2026
Piperacillin & Tazobactam for Injection · DIN 02362635 · 4 g & 500 mg · injection Pd-4.5g vial
Off-Formulary Interchangeable, not an ODB benefitMarketed · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot an ODB benefit; this DIN is on the ministry's EAP drug list (August 2026): submit an Exceptional Access request through SADIE with the clinical rationale; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Piperacillin & Tazobactam for Injection · DIN 02362635
Manufacturer: Sterimax Inc.; listing date 2016-06-29
Health Canada: Marketed since 2011-08-29 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients TAZOBACTAM (TAZOBACTAM SODIUM) 0.5 G/VIAL, PIPERACILLIN (PIPERACILLIN SODIUM) 4.0 G/VIAL · company Sterimax inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordPiperacillin & Tazobactam for Injection: Formulary list price $20.27 per unit (the source does not state the unit; exact figure $20.2700). What the ministry pays, not the patient.
Ministry pays: $20.2700 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02362635)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02362635).
DIN 02362635: Piperacillin & Tazobactam for Injection
Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y
Item: 081216102; group id 30; item number 0064; lccId None; manufacturer id STE
Source form: Inj Pd-4.5g Vial Pk; strength: 4g & 500mg
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed)
Source prices (unrounded): $20.2700; ministry $20.2700
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02362635
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84764
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402084 · $20.2700
Piperacillin & Tazobactam for Injection · DIN 02308460 · $20.2700
Piperacillin and Tazobactam for Inj · DIN 02401339 · $20.2700
Piperacillin/Tazobactam powder for Inj. · DIN 02370174 · $20.2700
Tazocin · DIN 02170809 · not recorded
Shortage status: resolved shortage (ended September 13, 2024); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02362635
Shortage record checked October 6, 2026
Piperacillin & Tazobactam for Injection · DIN 02308444 · 2 g & 250 mg · injection Pd-2.25g vial
Off-Formulary Interchangeable, not an ODB benefitDormant since August 3, 2018 · checked October 5, 2026 · What does dormant mean? StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot an ODB benefit; this DIN is on the ministry's EAP drug list (August 2026): submit an Exceptional Access request through SADIE with the clinical rationale; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Piperacillin & Tazobactam for Injection · DIN 02308444
Manufacturer: Apotex Inc.; listing date 2008-12-03
Health Canada: Dormant since 2018-08-03 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients TAZOBACTAM (TAZOBACTAM SODIUM) 0.25 G/VIAL, PIPERACILLIN (PIPERACILLIN SODIUM) 2 G/VIAL · company Apotex inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordPiperacillin & Tazobactam for Injection: Formulary list price $10.13 per unit (the source does not state the unit; exact figure $10.1300). What the ministry pays, not the patient.
Ministry pays: $10.1300 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02308444)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02308444).
DIN 02308444: Piperacillin & Tazobactam for Injection
Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y
Item: 081216101; group id 30; item number 0062; lccId None; manufacturer id APX
Source form: Inj Pd-2.25g Vial Pk; strength: 2g & 250mg
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed)
Source prices (unrounded): $10.1300; ministry $10.1300
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02308444
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=79408
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402068 · $10.1300
Piperacillin & Tazobactam for Injection · DIN 02362619 · $10.1300
Piperacillin and Tazobactam for Inj · DIN 02401312 · $10.1300
Tazocin · DIN 02170817 · not recorded
Shortage status: active shortage (reported October 1, 2014, last updated September 12, 2018) — report may be stale, confirm; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02308444
Shortage record checked October 6, 2026
Health Canada lists this DIN as Dormant since August 3, 2018 — choose a marketed DIN from the same-category list.
Piperacillin & Tazobactam for Injection · DIN 02308452 · 3 g & 375 mg · injection Pd-3.375g vial
Off-Formulary Interchangeable, not an ODB benefitDormant since August 4, 2017 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot an ODB benefit; the ministry's EAP drug list (August 2026) names this generic but not this DIN: confirm the product with the pharmacy or ministry before an Exceptional Access request; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Piperacillin & Tazobactam for Injection · DIN 02308452
Manufacturer: Apotex Inc.; listing date 2008-12-03
Health Canada: Dormant since 2017-08-04 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients PIPERACILLIN (PIPERACILLIN SODIUM) 3.0 G/VIAL, TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G/VIAL · company Apotex inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordPiperacillin & Tazobactam for Injection: Formulary list price $15.20 per unit (the source does not state the unit; exact figure $15.2000). What the ministry pays, not the patient.
Ministry pays: $15.2000 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02308452)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02308452).
DIN 02308452: Piperacillin & Tazobactam for Injection
Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y
Item: 081216097; group id 30; item number 0063; lccId None; manufacturer id APX
Source form: Inj Pd-3.375g Vial Pk; strength: 3g & 375mg
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed)
Source prices (unrounded): $15.2000; ministry $15.2000
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02308452
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=79409
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402076 · $15.2000
Piperacillin & Tazobactam for Injection · DIN 02362627 · $15.2000
Piperacillin & Tazobactam for Injection · DIN 02391538 · $15.2000
Piperacillin and Tazobactam for Inj · DIN 02401320 · $15.2000
Piperacillin/Tazobactam powder for Inj. · DIN 02370166 · $15.2000
Tazocin · DIN 02170795 · not recorded
Shortage status: active shortage (reported September 7, 2016, last updated September 12, 2018) — report may be stale, confirm; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02308452
Shortage record checked October 6, 2026
Health Canada lists this DIN as Dormant since August 4, 2017 — choose a marketed DIN from the same-category list.
Piperacillin & Tazobactam for Injection · DIN 02308460 · 4 g & 500 mg · injection Pd-4.5g vial
Off-Formulary Interchangeable, not an ODB benefitDormant since August 4, 2017 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot an ODB benefit; the ministry's EAP drug list (August 2026) names this generic but not this DIN: confirm the product with the pharmacy or ministry before an Exceptional Access request; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Piperacillin & Tazobactam for Injection · DIN 02308460
Manufacturer: Apotex Inc.; listing date 2008-12-03
Health Canada: Dormant since 2017-08-04 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients TAZOBACTAM (TAZOBACTAM SODIUM) 0.5 G/VIAL, PIPERACILLIN (PIPERACILLIN SODIUM) 4.0 G/VIAL · company Apotex inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordPiperacillin & Tazobactam for Injection: Formulary list price $20.27 per unit (the source does not state the unit; exact figure $20.2700). What the ministry pays, not the patient.
Ministry pays: $20.2700 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02308460)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02308460).
DIN 02308460: Piperacillin & Tazobactam for Injection
Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y
Item: 081216102; group id 30; item number 0064; lccId None; manufacturer id APX
Source form: Inj Pd-4.5g Vial Pk; strength: 4g & 500mg
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed)
Source prices (unrounded): $20.2700; ministry $20.2700
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02308460
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=79410
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402084 · $20.2700
Piperacillin & Tazobactam for Injection · DIN 02362635 · $20.2700
Piperacillin and Tazobactam for Inj · DIN 02401339 · $20.2700
Piperacillin/Tazobactam powder for Inj. · DIN 02370174 · $20.2700
Tazocin · DIN 02170809 · not recorded
Shortage status: active shortage (reported September 7, 2016, last updated October 5, 2017) — report may be stale, confirm; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02308460
Shortage record checked October 6, 2026
Health Canada lists this DIN as Dormant since August 4, 2017 — choose a marketed DIN from the same-category list.
Piperacillin and Tazobactam for Inj · DIN 02401312 · 2 g & 250 mg · injection Pd-2.25g vial
Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2023-01-01 — choose a marketed DIN from the same-category list.Discontinued January 1, 2023 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2023-01-01 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; this DIN is on the ministry's EAP drug list (August 2026): submit an Exceptional Access request through SADIE with the clinical rationale; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2023-01-01 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Piperacillin and Tazobactam for Inj · DIN 02401312
Manufacturer: Teligent OU; listing date 2018-11-29
Health Canada: Cancelled post market since 2023-01-01 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients TAZOBACTAM (TAZOBACTAM SODIUM) 0.25 G/VIAL, PIPERACILLIN (PIPERACILLIN SODIUM) 2 G/VIAL · company Hikma canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordPiperacillin and Tazobactam for Inj: Formulary list price $10.13 per unit (the source does not state the unit; exact figure $10.1300). What the ministry pays, not the patient.
Ministry pays: $10.1300 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02401312)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02401312).
DIN 02401312: Piperacillin and Tazobactam for Inj
Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y
Item: 081216101; group id 30; item number 0062; lccId None; manufacturer id TEL
Source form: Inj Pd-2.25g Vial Pk; strength: 2g & 250mg
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed)
Source prices (unrounded): $10.1300; ministry $10.1300
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02401312
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88623
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402068 · $10.1300
Piperacillin & Tazobactam for Injection · DIN 02308444 · $10.1300
Piperacillin & Tazobactam for Injection · DIN 02362619 · $10.1300
Tazocin · DIN 02170817 · not recorded
Shortage status: resolved shortage (ended July 21, 2022); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02401312
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since January 1, 2023 — choose a marketed DIN from the same-category list.
Tazocin · DIN 02170817 · 2 g & 250 mg · injection Pd-2.25g vial
Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2015-04-27 — choose a marketed DIN from the same-category list.Discontinued April 27, 2015 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2015-04-27 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; the ministry's EAP drug list (August 2026) names this generic but not this DIN: confirm the product with the pharmacy or ministry before an Exceptional Access request; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2015-04-27 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Tazocin · DIN 02170817
Manufacturer: Pfizer Canada Inc.; listing date 2008-12-03
Health Canada: Cancelled post market since 2015-04-27 · brand TAZOCIN · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients PIPERACILLIN (PIPERACILLIN SODIUM) 2 G/VIAL, TAZOBACTAM (TAZOBACTAM SODIUM) 250 MG/VIAL · company Pfizer canada ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordTazocin: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02170817)
Source record
DIN 02170817: Tazocin
Raw flags: sec3=Y, sec3b=Y
Item: 081216101; group id 30; item number 0062; lccId None; manufacturer id PFI
Source form: Inj Pd-2.25g Vial Pk; strength: 2g & 250mg
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02170817
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=44170
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402068 · $10.1300
Piperacillin & Tazobactam for Injection · DIN 02308444 · $10.1300
Piperacillin & Tazobactam for Injection · DIN 02362619 · $10.1300
Piperacillin and Tazobactam for Inj · DIN 02401312 · $10.1300
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02170817
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since April 27, 2015 — choose a marketed DIN from the same-category list.
Piperacillin & Tazobactam for Injection · DIN 02391538 · 3 g & 375 mg · injection Pd-3.375g vial
Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2016-07-06 — choose a marketed DIN from the same-category list.Discontinued July 6, 2016 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2016-07-06 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; the ministry's EAP drug list (August 2026) names this generic but not this DIN: confirm the product with the pharmacy or ministry before an Exceptional Access request; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2016-07-06 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Piperacillin & Tazobactam for Injection · DIN 02391538
Manufacturer: Mylan Pharmaceuticals ULC; listing date 2012-12-21
Health Canada: Cancelled post market since 2016-07-06 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G/VIAL, PIPERACILLIN (PIPERACILLIN SODIUM) 3 G/VIAL · company Mylan pharmaceuticals ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordPiperacillin & Tazobactam for Injection: Formulary list price $15.20 per unit (the source does not state the unit; exact figure $15.2000). What the ministry pays, not the patient.
Ministry pays: $15.2000 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02391538)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02391538).
DIN 02391538: Piperacillin & Tazobactam for Injection
Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y
Item: 081216097; group id 30; item number 0063; lccId None; manufacturer id MYL
Source form: Inj Pd-3.375g Vial Pk; strength: 3g & 375mg
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed)
Source prices (unrounded): $15.2000; ministry $15.2000
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02391538
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87686
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402076 · $15.2000
Piperacillin & Tazobactam for Injection · DIN 02308452 · $15.2000
Piperacillin & Tazobactam for Injection · DIN 02362627 · $15.2000
Piperacillin and Tazobactam for Inj · DIN 02401320 · $15.2000
Piperacillin/Tazobactam powder for Inj. · DIN 02370166 · $15.2000
Tazocin · DIN 02170795 · not recorded
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02391538
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since July 6, 2016 — choose a marketed DIN from the same-category list.
Piperacillin and Tazobactam for Inj · DIN 02401320 · 3 g & 375 mg · injection Pd-3.375g vial
Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2022-09-09 — choose a marketed DIN from the same-category list.Discontinued September 9, 2022 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2022-09-09 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; this DIN is on the ministry's EAP drug list (August 2026): submit an Exceptional Access request through SADIE with the clinical rationale; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2022-09-09 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Piperacillin and Tazobactam for Inj · DIN 02401320
Manufacturer: Teligent OU; listing date 2018-11-29
Health Canada: Cancelled post market since 2022-09-09 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G/VIAL, PIPERACILLIN (PIPERACILLIN SODIUM) 3 G/VIAL · company Hikma canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordPiperacillin and Tazobactam for Inj: Formulary list price $15.20 per unit (the source does not state the unit; exact figure $15.2000). What the ministry pays, not the patient.
Ministry pays: $15.2000 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02401320)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02401320).
DIN 02401320: Piperacillin and Tazobactam for Inj
Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y
Item: 081216097; group id 30; item number 0063; lccId None; manufacturer id TEL
Source form: Inj Pd-3.375g Vial Pk; strength: 3g & 375mg
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed)
Source prices (unrounded): $15.2000; ministry $15.2000
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02401320
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88624
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402076 · $15.2000
Piperacillin & Tazobactam for Injection · DIN 02308452 · $15.2000
Piperacillin & Tazobactam for Injection · DIN 02362627 · $15.2000
Piperacillin & Tazobactam for Injection · DIN 02391538 · $15.2000
Piperacillin/Tazobactam powder for Inj. · DIN 02370166 · $15.2000
Tazocin · DIN 02170795 · not recorded
Shortage status: resolved shortage (ended July 21, 2022); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02401320
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since September 9, 2022 — choose a marketed DIN from the same-category list.
Piperacillin/Tazobactam powder for Inj. · DIN 02370166 · 3 g & 375 mg · injection Pd-3.375g vial
Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2019-11-18 — choose a marketed DIN from the same-category list.Discontinued November 18, 2019 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2019-11-18 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; this DIN is on the ministry's EAP drug list (August 2026): submit an Exceptional Access request through SADIE with the clinical rationale; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2019-11-18 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Piperacillin/Tazobactam powder for Inj. · DIN 02370166
Manufacturer: Teva Canada Limited; listing date 2012-07-27
Health Canada: Cancelled post market since 2019-11-18 · brand PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients PIPERACILLIN (PIPERACILLIN SODIUM) 3 G/VIAL, TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G/VIAL · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordPiperacillin/Tazobactam powder for Inj.: Formulary list price $15.20 per unit (the source does not state the unit; exact figure $15.2000). What the ministry pays, not the patient.
Ministry pays: $15.2000 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02370166)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02370166).
DIN 02370166: Piperacillin/Tazobactam powder for Inj.
Raw flags: dinStatus=E, sec3=Y, sec3b=Y, sec3bEAP=Y
Item: 081216097; group id 30; item number 0063; lccId None; manufacturer id TEV
Source form: Inj Pd-3.375g Vial Pk; strength: 3g & 375mg
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed); DIN status E, meaning unconfirmed
Source prices (unrounded): $15.2000; ministry $15.2000
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02370166
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=85518
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402076 · $15.2000
Piperacillin & Tazobactam for Injection · DIN 02308452 · $15.2000
Piperacillin & Tazobactam for Injection · DIN 02362627 · $15.2000
Piperacillin & Tazobactam for Injection · DIN 02391538 · $15.2000
Piperacillin and Tazobactam for Inj · DIN 02401320 · $15.2000
Tazocin · DIN 02170795 · not recorded
Shortage status: discontinued (March 30, 2022, reported by TEVA CANADA LIMITED); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02370166
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since November 18, 2019 — choose a marketed DIN from the same-category list.
Tazocin · DIN 02170795 · 3 g & 375 mg · injection Pd-3.375g vial
Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2015-02-26 — choose a marketed DIN from the same-category list.Discontinued February 26, 2015 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2015-02-26 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; the ministry's EAP drug list (August 2026) names this generic but not this DIN: confirm the product with the pharmacy or ministry before an Exceptional Access request; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2015-02-26 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Tazocin · DIN 02170795
Manufacturer: Wyeth Ltd.; listing date 2008-12-03
Health Canada: Cancelled post market since 2015-02-26 · brand TAZOCIN · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients PIPERACILLIN (PIPERACILLIN SODIUM) 3 G/VIAL, TAZOBACTAM (TAZOBACTAM SODIUM) 375 MG/VIAL · company Pfizer canada ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordTazocin: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02170795)
Source record
DIN 02170795: Tazocin
Raw flags: sec3=Y, sec3b=Y
Item: 081216097; group id 30; item number 0063; lccId None; manufacturer id WYE
Source form: Inj Pd-3.375g Vial Pk; strength: 3g & 375mg
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02170795
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=44168
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402076 · $15.2000
Piperacillin & Tazobactam for Injection · DIN 02308452 · $15.2000
Piperacillin & Tazobactam for Injection · DIN 02362627 · $15.2000
Piperacillin & Tazobactam for Injection · DIN 02391538 · $15.2000
Piperacillin and Tazobactam for Inj · DIN 02401320 · $15.2000
Piperacillin/Tazobactam powder for Inj. · DIN 02370166 · $15.2000
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02170795
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since February 26, 2015 — choose a marketed DIN from the same-category list.
Piperacillin and Tazobactam for Inj · DIN 02401339 · 4 g & 500 mg · injection Pd-4.5g vial
Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2022-06-02 — choose a marketed DIN from the same-category list.Discontinued June 2, 2022 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2022-06-02 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; this DIN is on the ministry's EAP drug list (August 2026): submit an Exceptional Access request through SADIE with the clinical rationale; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2022-06-02 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Piperacillin and Tazobactam for Inj · DIN 02401339
Manufacturer: Teligent OU; listing date 2018-11-29
Health Canada: Cancelled post market since 2022-06-02 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients TAZOBACTAM (TAZOBACTAM SODIUM) 0.5 G/VIAL, PIPERACILLIN (PIPERACILLIN SODIUM) 4 G/VIAL · company Hikma canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordPiperacillin and Tazobactam for Inj: Formulary list price $20.27 per unit (the source does not state the unit; exact figure $20.2700). What the ministry pays, not the patient.
Ministry pays: $20.2700 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02401339)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02401339).
DIN 02401339: Piperacillin and Tazobactam for Inj
Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y
Item: 081216102; group id 30; item number 0064; lccId None; manufacturer id TEL
Source form: Inj Pd-4.5g Vial Pk; strength: 4g & 500mg
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed)
Source prices (unrounded): $20.2700; ministry $20.2700
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02401339
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88625
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402084 · $20.2700
Piperacillin & Tazobactam for Injection · DIN 02308460 · $20.2700
Piperacillin & Tazobactam for Injection · DIN 02362635 · $20.2700
Piperacillin/Tazobactam powder for Inj. · DIN 02370174 · $20.2700
Tazocin · DIN 02170809 · not recorded
Shortage status: resolved shortage (ended July 21, 2022); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02401339
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since June 2, 2022 — choose a marketed DIN from the same-category list.
Piperacillin/Tazobactam powder for Inj. · DIN 02370174 · 4 g & 500 mg · injection Pd-4.5g vial
Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2018-02-20 — choose a marketed DIN from the same-category list.Discontinued February 20, 2018 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2018-02-20 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; this DIN is on the ministry's EAP drug list (August 2026): submit an Exceptional Access request through SADIE with the clinical rationale; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2018-02-20 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Piperacillin/Tazobactam powder for Inj. · DIN 02370174
Manufacturer: Teva Canada Limited; listing date 2012-07-27
Health Canada: Cancelled post market since 2018-02-20 · brand PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients TAZOBACTAM (TAZOBACTAM SODIUM) 0.5 G/VIAL, PIPERACILLIN (PIPERACILLIN SODIUM) 4 G/VIAL · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordPiperacillin/Tazobactam powder for Inj.: Formulary list price $20.27 per unit (the source does not state the unit; exact figure $20.2700). What the ministry pays, not the patient.
Ministry pays: $20.2700 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02370174)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02370174).
DIN 02370174: Piperacillin/Tazobactam powder for Inj.
Raw flags: dinStatus=E, sec3=Y, sec3b=Y, sec3bEAP=Y
Item: 081216102; group id 30; item number 0064; lccId None; manufacturer id TEV
Source form: Inj Pd-4.5g Vial Pk; strength: 4g & 500mg
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed); DIN status E, meaning unconfirmed
Source prices (unrounded): $20.2700; ministry $20.2700
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02370174
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=85519
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402084 · $20.2700
Piperacillin & Tazobactam for Injection · DIN 02308460 · $20.2700
Piperacillin & Tazobactam for Injection · DIN 02362635 · $20.2700
Piperacillin and Tazobactam for Inj · DIN 02401339 · $20.2700
Tazocin · DIN 02170809 · not recorded
Shortage status: discontinued (March 30, 2022, reported by TEVA CANADA LIMITED); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02370174
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since February 20, 2018 — choose a marketed DIN from the same-category list.
Tazocin · DIN 02170809 · 4 g & 500 mg · injection Pd-4.5g vial
Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2015-04-27 — choose a marketed DIN from the same-category list.Discontinued April 27, 2015 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2015-04-27 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; the ministry's EAP drug list (August 2026) names this generic but not this DIN: confirm the product with the pharmacy or ministry before an Exceptional Access request; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2015-04-27 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Tazocin · DIN 02170809
Manufacturer: Wyeth Ltd.; listing date 2008-12-03
Health Canada: Cancelled post market since 2015-04-27 · brand TAZOCIN · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients PIPERACILLIN (PIPERACILLIN SODIUM) 4 G/VIAL, TAZOBACTAM (TAZOBACTAM SODIUM) 500 MG/VIAL · company Pfizer canada ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordTazocin: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02170809)
Source record
DIN 02170809: Tazocin
Raw flags: sec3=Y, sec3b=Y
Item: 081216102; group id 30; item number 0064; lccId None; manufacturer id WYE
Source form: Inj Pd-4.5g Vial Pk; strength: 4g & 500mg
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02170809
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=44169
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402084 · $20.2700
Piperacillin & Tazobactam for Injection · DIN 02308460 · $20.2700
Piperacillin & Tazobactam for Injection · DIN 02362635 · $20.2700
Piperacillin and Tazobactam for Inj · DIN 02401339 · $20.2700
Piperacillin/Tazobactam powder for Inj. · DIN 02370174 · $20.2700
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02170809
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since April 27, 2015 — choose a marketed DIN from the same-category list.
Other products in the same Health Canada class (J01C, J01CR): coverage varies; not interchangeable
- Amoxicillin + clavulanic acid (Clavulin): general benefit, not a benefit
- Amoxicillin (Novamoxin): general benefit, not a benefit, listing status unconfirmed
- Ampicillin (Penbritin): general benefit, not a benefit
- Cloxacillin (Orbenin): general benefit, not a benefit
- Penicillin v (Nadopen-V): general benefit, not a benefit